Home › Diffuse Large B-Cell Lymphoma › Pennsylvania › Philadelphia

Pag-aaral pangklinika para sa Diffuse Large B-Cell Lymphoma sa Philadelphia, PA

Isang pag-aaral para sa Diffuse Large B-Cell Lymphoma ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Philadelphia. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

Nagha-hire para sa pag-aaral dito? I-highlight ito sa tuktok ng pahinang ito — $99 sa loob ng 30 araw →

A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011)

Nagre-recruitPhase 2

Abramson Cancer Center and Perelman Center for Advanced Medicine ( Site 0131), Philadelphia
Temple University Hospital ( Site 0133), Philadelphia

Edad 18 pataas · Lahat ng kasarian · Na-update Nob 13, 2026 · NCT06890884

Testing the Effectiveness of a Combination Targeted Therapy (ViPOR) for Patients With Relapsed and/or Refractory Aggressive B-cell Lymphoma

Nagre-recruitPhase 2

Thomas Jefferson University Hospital, Philadelphia

Edad 18 pataas · Lahat ng kasarian · Na-update Nob 9, 2026 · NCT06649812

A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )

Nagre-recruitPhase 1

University of Pennsylvania Abramson Cancer Center, Philadelphia

Edad 18 pataas · Lahat ng kasarian · Na-update Nob 4, 2026 · NCT07101328

A Study of Zilovertamab Vedotin (MK-2140) in Combination With Standard of Care in Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (rrDLBCL) (MK-2140-003)

Nagre-recruitPhase 2/3

Alliance Cancer Specialists (ACS) ( Site 8001), Horsham · 16 mi ang layo

Edad 18 pataas · Lahat ng kasarian · Na-update Nob 3, 2026 · NCT05139017

Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)

Nagre-recruitPhase 1/2

Children's Hospital of Philadelphia (CHOP) ( Site 1021), Philadelphia

6 Months – 25 Years · Lahat ng kasarian · Na-update Okt 30, 2026 · NCT06395103

Consolidation of First-Line MRD+ Remission With Cema-cel in Patients With LBCL

Nagre-recruitPhase 2

Fox Chase Cancer Center, Philadelphia

Edad 18 pataas · Lahat ng kasarian · Na-update Okt 30, 2026 · NCT06500273

Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution

Nagre-recruitObservasyonal na pag-aaral

Children's Hospital of Philadelphia, Philadelphia

Edad 0 hanggang 38 · Lahat ng kasarian · Na-update Okt 29, 2026 · NCT06131801

Testing Drug Treatments After CAR T-cell Therapy in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma

Nagre-recruitPhase 2

University of Pennsylvania/Abramson Cancer Center, Philadelphia

Edad 18 pataas · Lahat ng kasarian · Na-update Okt 15, 2026 · NCT05633615

Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma

Nagre-recruitPhase 1/2

Thomas Jefferson University, Philadelphia

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 25, 2026 · NCT05826535

A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas

Nagre-recruitPhase 1/2

Abramson Cancer Center of the University of Pennsylvania, Philadelphia

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 19, 2026 · NCT04104776

Immune Cell Therapy (CAR-T) for the Treatment of Patients With HIV and B-Cell Non-Hodgkin Lymphoma

Nagre-recruitPhase 1

University of Pennsylvania / Abramson Cancer Center, Philadelphia

Edad 18 pataas · Lahat ng kasarian · Na-update Hul 10, 2026 · NCT05077527

A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies

Nagre-recruitPhase 1

University of Pennsylvania, Abramson Cancer Center, Philadelphia

Edad 18 pataas · Lahat ng kasarian · Na-update Hul 2, 2026 · NCT05131022

Radiation, Oral Vancomycin, and CAR-T for B-Cell Lymphomas

Nagre-recruitPhase 1

Abramson Cancer Center, University of Pennsylvania, Philadelphia

Edad 18 pataas · Lahat ng kasarian · Na-update Hul 1, 2026 · NCT07478848

Epcoritamab-CAR T Cells for Large B-cell Lymphomas

Nagre-recruitPhase 2

Abramson Cancer Center at the University of Pennsylvania, Philadelphia

Edad 18 pataas · Lahat ng kasarian · Na-update May 27, 2026 · NCT06458439

SynKIR-310 for Relapsed/Refractory B-NHL

Nagre-recruitPhase 1

Abramson Cancer Center of the University of Pennsylvania, Philadelphia

Edad 18 pataas · Lahat ng kasarian · Na-update Abr 14, 2026 · NCT06544265

Pag-aaral para sa Diffuse Large B-Cell Lymphoma sa ibang lungsod

Iba pang pag-aaral sa Philadelphia

Mula sa ClinicalTrials.gov, na-kuha noong Nob 15, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.